[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
July 10, 2000

Continued Dependence on Nicotine Replacement Therapy Should Be Reported and Discussed in Smoking Cessation Trials—Reply

Author Affiliations

Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000

Arch Intern Med. 2000;160(13):2061-2067. doi:

In reply

Gylys questioned why continued nicotine replacement therapy (NRT) use rates were not reported in our study.1 The introductory section of our article concluded with a clear statement that findings regarding the products' dependence potential will be reported separately. This article has been accepted for publication in Psychopharmacology, and it will appear shortly.2 There was never any intention not to report these findings. Gylys came to this conclusion on the basis of misinterpreting a sentence from another context. Like Gylys, we consider this topic important. Indeed, we examined this in sufficient depth to warrant a full separate report.